E
EWTX
Edgewise Therapeutics, Inc.
32.70
+0.01+0.03%After Hours: 33.28 +0.58 +1.77%17:43 05/22 EDT
OPEN/PREV CLOSE32.92/32.69
TODAY RANGE32.32-33.55
VOL681.41K
MARKET CAP3.52B
52 WEEK RANGE12.15-39.96
AVG VOL (3M)1.03M
% TURNOVER0.63%
TURNOVER--
P/E (TTM)-19.6905
% RANGE3.76%
EPS(TTM)-1.6607
P/E(FORWARD)-16.1881
P/B7.13
BVPS4.589
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.85B
SHARES OUTSTANDING107.59M
NEXT EARNINGS08/05-08/10
FREE FLOAT87.16M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·5d ago
Assessing Edgewise Therapeutics (EWTX) Valuation After Strong Multi Year Shareholder Returns
TipRanks·05/12 18:28
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
TipRanks·05/12 12:11
Goldman Sachs Sticks to Its Hold Rating for Edgewise Therapeutics (EWTX)
TipRanks·05/11 17:54
Trump approves plan to fire FDA head Marty Makary, CBS reports
TipRanks·05/11 02:37
Stifel Nicolaus Remains a Hold on Edgewise Therapeutics (EWTX)
TipRanks·05/08 19:05
Trump plans to fire FDA commissioner Marty Makary, WSJ reports
TipRanks·05/08 16:55
Edgewise Therapeutics (EWTX) Receives a Buy from Evercore ISI
TipRanks·05/08 12:54
Edgewise Therapeutics (EWTX) Receives a Buy from Wedbush
TipRanks·05/08 11:35
H.C. Wainwright Sticks to Its Buy Rating for Edgewise Therapeutics (EWTX)
TipRanks·05/07 13:16
Edgewise Therapeutics reports Q1 EPS (46c), consensus (49c)
Seeking Alpha·05/07 12:27
Edgewise Therapeutics GAAP EPS of -$0.46
Reuters·05/07 12:11
Edgewise Therapeutics Q1 net loss widens on higher R&D costs
PUBT·05/07 12:08
Edgewise net loss widens to $49 million in Q1 FY26